Live Breaking News & Updates on Polpharma

Stay informed with the latest breaking news from Polpharma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Polpharma and stay connected to the pulse of your community

Kazakh President, Polpharma SA Supervisory Board Chairman hold talks

ASTANA. KAZINFORM Kazakh President Kassym-Jomart Tokayev met with Chairman of Polpharma SA Supervisory Board Jerzy Starak to discuss the key directions of the company’s activities in Kazakhstan and its participation in the development of joint pharmaceutical projects, Kazinform cites the Akorda press service.

Astana , Gorod-astana , Kazakhstan , Jerzy-starak , Kassym-jomart-tokayev , President-kassym-jomart-tokayev , Board-jerzy-starak , President-of-kazakhstan , Kazakh , President , Polpharma

Box, Inc.: Polpharma Biologics, European Biotechnology Company, Selects Box for Cloud Content Management

Box, Inc. (NYSE: Box), the leading Content Cloud, today announced that Polpharma Biologics has chosen Box to power secure cloud content management and collaboration. A European biotechnology company

United-states , Netherlands , Poland , Polpharma-biologics , Tiffany-kirkland , Bartlomiej-piernicki , Amgen , Morgan-stanley , Box-inc , Regulatory-affairs , Business-technology-at-polpharma-biologics , Astrazeneca

Polpharma Biologics Announces Rebrand and Launch of New Value We Care as 2000 L Bioreactors Begin Validation at Its Warsaw Site


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005383/en/
Dr Joerg Windisch, CEO of Polpharma Biologics, said "Our new brand represents our passion and dedication to innovation, we utilize the latest technology and cutting-edge techniques to discover and advance ground breaking biologics to the clinic, whether this is our own pipeline or that of our partners.
The industry is rapidly reducing the time to develop and manufacture new molecules, this is down to significant improvements in automation with many previously time consuming steps replaced with equipment that can analyze thousands of samples in minutes incredibly accurately. Throughout our entire process from early stage discovery, through cell line development and process development and to fill finish we have adopted the very latest technology to ensure we can offer the best timelines and most comprehensive analytics to generate the highest quality biologic drugs, our new brand represents our commitment to this innovation."

Netherlands , Poland , Warsaw , Pl67 , Polpharma-biologics , Kostenloser-wertpapierhandel , Joerg-windisch , Frank-ternes , Global-head , Polpharma , Biologics